Daily Roundup / Teva set aside $5m from Israel profit for tax in 2012
It also wins big patent case; Elbit agrees to sell self-defense systems with Boeing; Biogroup stock soars after step to make bone alone; Liveperson beat forecasts, and Spacenet gets star contract.
Teva taxing the public's patience? The public has been growling over the sweetheart tax rates paid by multinationals. In 2012, Teva Pharmaceutical Industries set aside just $5 million for tax from its profits made in Israel, following large accounting charges, notably a $670 million provision for a patent challenge over the drug Protonix. Actual tax paid was higher, though the drug...
Like us on Facebook and get articles directly in your news feed